An International, Phase III, Randomized, Double-Blinded, Placebo-Controlled, Multi-Center Study to Assess the Efficacy of ZD6474 (ZACTIMATM) Versus Placebo in Subjects With Unresectable Locally Advanced or Metastatic Medullary Thyroid Cancer
收藏DataCite Commons2025-09-02 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00007740/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to learn how hereditary or sporadic medullary thyroid cancer
patients, treated with ZD6474, react to the drug, what happens to ZD6474 in the human body,
about the side effects of ZD6474, and if ZD6474 can decrease or prevent the growth of tumors.
提供机构：
Vivli
创建时间：
2022-02-10
